| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |